Sexual Health Sexual Health Society
Publishing on sexual health from the widest perspective

Knowledge and awareness of human papillomavirus (HPV): attitudes towards HPV vaccination among a representative sample of women in Victoria, Australia

Marian K. Pitts A D , Suzanne J. Dyson A , Doreen A. Rosenthal B and Suzanne M. Garland C
+ Author Affiliations
- Author Affiliations

A Australian Research Centre in Sex, Health and Society, La Trobe University, 215 Franklin Street, Melbourne, Vic. 3000, Australia.

B Key Centre for Women’s Health in Society, University of Melbourne, Melbourne, Vic. 3010, Australia.

C Department of Microbiology and Infectious Diseases, Royal Women’s Hospital, 132 Grattan Street, Carlton, Vic. 3053, Australia.

D Corresponding author. Email:

Sexual Health 4(3) 177-180
Submitted: 13 April 2007  Accepted: 5 July 2007   Published: 23 August 2007


Background: A vaccine program is underway to protect women against human papillomavirus (HPV) and thus cervical cancer. Previous studies have reported very low levels of HPV knowledge and there has been concern that preventative vaccines might not be readily accepted, given that HPV is transmitted sexually and the optimal time for vaccination is before sexual debut. Methods: A computer-assisted telephone survey was carried out with a representative sample of 1100 women aged 18 to 61 years, randomly selected from households in Victoria, Australia, to investigate knowledge and attitudes about HPV and attitudes towards HPV vaccination. Results: Half of the participants (51%) had heard of HPV; most reported learning about it from the media. Most women indicated they would trust their general practitioner (96.3%), a gynaecologist or specialist doctor (99.6%), or a women’s health service (97.0%) for information about HPV. Few women (11.9%) had ever sought information about HPV and only 14.8% of the total sample had ever discussed HPV with a friend. Strong support was found for vaccination in general and there was also significant support for a HPV vaccine. Conclusion: The present study documents ways in which women learn about HPV and indicates the potential for success of a vaccination program.

Additional keywords: cervical cancer.


The concept of this study was by SG, study design and analysis of results was by MP, DR and SG supervised the project administration. All authors contributed to the writing of the paper. We are grateful to GSK for a grant-in-aid to the Royal Women’s Hospital to support this project. GSK Australia had no involvement with the object design or data analysis.


[1] Koutsky LA,  Ault KA,  Wheeler CM,  Brown DR,  Barr E,  Alvarez FB, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002; 347 1645–51.
CrossRef | PubMed |

[2] Harper DM,  Franc EL,  Wheeler C,  Ferris D,  Jenkins D,  Schiund A, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. GlaxoSmithKline HPV vaccine study group. Lancet 2004; 364 1757–65.
CrossRef | PubMed |

[3] IDSA abstract Oct 2005 43rd Annual meeting of IDSA, October 6–9 2005, San Francisco, Prophylactic quadrivalent human papillomavirus (HPV) (types 6, 11, 16, 18) L1 virus-like particle (VLP) vaccine (Gardasil) reduces cervical intraepithelial neoplasia (CIN) 2/3 risk Skjeldestad F for the Future II Steering Committee; Dept of Epidemiology, SINTEF Health Research, Trondheim, Norway.

[4] Efficacy of a prophylactic quadrivalent human papillomavirus (HPV) (Types 6, 11, 16, 18) L1 Virus-like particle (VLP) vaccine for Prevention of cervical dysplasia and external genital lesions (EGL) D Harper, for the FUTURE Investigators. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 2005 December 16–19; Washington, DC.

[5] Baer H,  Allen S,  Braun L. Knowledge of human papillomavirus infection among young adult men and women: implication for the health education and research. J Community Health 2000; 25 67–78.
CrossRef | PubMed |

[6] Boyd C . An assessment of college students’ knowledge and perception of risk regarding human papilloma virus and related health promotion strategies for campus health personnel. [Ph.D]: Ohio University, 1998.

[7] Holcomb B,  Bailey JM,  Crawford K,  Ruffin MT. Adults’ knowledge and behaviors related to human papillomavirus infection. J Am Board Fam Pract 2004; 17 26–31.
PubMed |

[8] Hoover DR,  Carfoli B,  Moench E. Attitudes of adolescent/young adult women towards human papillomavirus vaccination and clinical trials. Health Care Women Int 2000; 21 375–91.
CrossRef | PubMed |

[9] Mays RM,  Zimet G,  Winston Y,  Kee R,  Dickes J,  Su L. Human papillomavirus, genital warts, Pap smears, and cervical cancer: knowledge and beliefs of adolescent and adult women. Health Care Women Int 2000; 21 361–74.
CrossRef | PubMed |

[10] Pitts MK,  Clarke T. Human papillomavirus infections and risks of cervical cancer: what do women know? Health Educ Res 2002; 17 706–14.
CrossRef | PubMed |

[11] Waller J,  McCaffery K,  Forrest S,  Szarewski A,  Cadman L,  Wardle J. Awareness of human papillomavirus among women attending a well women clinic. Sex Transm Infect 2003; 79 320–2.
CrossRef | PubMed |

[12] Gudmundsdóttir T,  Tryggvadóttir L,  Allende M,  Mast T. Eligibility and willingness of young Icelandic women to participate in a HPV vaccination trial. Acta Obstet Gynecol Scand 2003; 82 345–50.
CrossRef | PubMed |

[13] McClelland A,  Liamputtong P. Knowledge and acceptance of human papillomavirus vaccination: perspectives of young Australians living in Melbourne, Australia. Sex Health 2006; 3 95–101.
CrossRef | PubMed |

[14] Brabin L,  Roberts SA,  Farzaneh F,  Kitchener H. Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. Vaccine 2006; 24 3087–94.
CrossRef | PubMed |

[15] Garland SM. Human papillomavirus vaccines: challenges to implementation. Sex Health 2006; 3 63–5.
CrossRef | PubMed |

Rent Article (via Deepdyve) Export Citation Cited By (46)